Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials

Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases. One such strategy comes from a new abstract being presented Oct. 28 at the 15th World Conference on Lung Cancer from researchers at Perelman School of Medicine at the University of Pennsylvania studying mesothelioma.

Fuente : http://www.eurekalert.org/pub_releases/2013-10/uop…



Hacer un comentario